Atlas Trials

Effect of Increasing Total Antioxidant Capacity in Autism Spectrum Disorder

Clinical trial NCT06623227 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06623227
Sponsor
Rinvil Renaldi
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2024-09-28
Primary completion
2025-01-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.